WatchGov

Virginia bills · 2026 Regular Session

Virginia SB 404

Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Summary

Official abstract published by the Virginia legislature· SUMMARY AS PASSED

Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is identical to HB 800.

Text versions

Roll-call votes

State vote data last updated Oct 14, 2026, 8:13 PM.

DateVoteResultYour legislators
Feb 25, 2026
House		H VOTE:passSet your home in Virginia to see
Feb 20, 2026
House		Reported from AppropriationspassSet your home in Virginia to see
Jan 30, 2026
Senate		Passage RpassSet your home in Virginia to see
Jan 28, 2026
Senate		Constitutional reading dispensed RpassSet your home in Virginia to see
Jan 27, 2026
Senate		Reported from Finance and AppropriationspassSet your home in Virginia to see

Actions